Zdrowie i gospodarka · 23/08/2018
FDA Announces Draft Guidance for Osteoarthritis Treatment Development
The FDA is releasing a draft guidance to help pharmaceutical companies develop effective treatments for osteoarthritis, focusing on structural endpoints rather than symptom relief.